The use of PLLA in nonfacial areas such as the buttocks and décolletage is associated with a low rate of mild and moderate AEs.

The FDA moved approved marijuana products to schedule III to expand therapy access and state medical programs while maintaining federal controls.

For all of Trump’s efforts, the share of Americans likely to benefit from lower drug prices remains slim, even if some do come out ahead.

After months of pressure from the Trump administration, US Food and Drug Administration Commissioner Dr Marty Makary has quit.

Despite a sharp uptick in the use of GLP-1 receptor agonists, most US adults with severe obesity do not receive treatment.

Sixteen passengers from the cruise ship at the center of a deadly hantavirus outbreak are being monitored at a quarantine center in Nebraska.

The American Academy of Dermatology issued an update to their 2014 guidelines on the management of pediatric atopic ...

An acne management guideline was updated, which includes new considerations for isotretinoin, hormonal therapies, new topical ...

Bimekizumab is associated with significant complete clearance rates at 4 years among patients with scalp, nail, or palmoplantar psoriasis.

A targeted birth-dose vaccine recommendation for hepatitis B virus in the United States would likely increase neonatal infections.

Coverage of several self-administered DMARDs declined across Medicare Part D plans between 2022 and 2026, with differential coverage noted across plan types.

Aluminum-adjuvanted vaccines showed no association with long-term health outcomes, including asthma and autism spectrum disorder.